Insurers' large and growing exposure to private credit creates a real, though still unpriced, channel of
financial risk and possible contagion from a valuation or liquidity shock.
Insurer Private Credit Exposure
$2T
Private Credit Held
18%
Of All Bond Holdings
⚠ Morgan Stanley gate: withdrawals limited to 5% — signaling
liquidity stress
What Aronov's warning implies
- Insurers owning ~$2 trillion of private credit (roughly 18% of bond holdings) highlights a basic problem: these assets are illiquid and hard to value reliably between transactions.
- When a large manager like Morgan Stanley restricts withdrawals in a private credit vehicle, it is effectively admitting that "net asset value" is not easily convertible to cash at scale — which is exactly the risk facing insurers if they ever need to sell quickly.
Why private credit is attractive to insurers
- Higher yields and an "illiquidity premium" make private loans very appealing to life and annuity writers who need long‑dated, predictable cash flows to back guarantees.
- In North America, private credit now accounts for a very significant share (often around a third or more) of insurers' investment portfolios, particularly life companies, and this share has been rising despite higher public‑market yields.[3][5][7]
- For many insurers, the business model assumes "buy and hold to maturity," so day‑to‑day market liquidity seems less critical — until stress hits.
Key financial risks for insurers
1
Valuation Risk
2
Liquidity & Surrender Risk
- In normal times, insurers fund illiquid assets with "sticky" liabilities (life/annuity contracts), but rising rates or loss of confidence can trigger policy surrenders.
- If many policyholders demand cash at once, insurers might be forced to sell private credit into a thin market at distressed prices, crystallizing "unrealized" losses.[2][4][6]
- Withdrawal gates (like the 5% limit) are one way managers slow this; insurers themselves have fewer tools once policyholders want out.
3
Credit Quality & Concentration
- A meaningful share sits in lower‑rated or borderline investment‑grade buckets (Baa or below), which are more sensitive to downturns.[6][2][5]
- Concentrations in CRE, asset‑based finance, and structured vehicles (CLOs/CFOs) add sector‑specific shock risk if correlated exposures come under stress at once.[7][5]
Contagion channels beyond insurers
If valuations prove inflated and have to "catch up" with reality, the damage can spread outside hedge funds into the real economy and everyday insurance products:
Contagion Transmission Chain
Stage 1
Write-downs hit capital ratios
Stage 2
Rating downgrades & forced de-risking
Stage 3
Product repricing & policyholder flight
Stage 4
Credit tightening for mid-market borrowers
- Capital & ratings pressure: Large write-downs reduce regulatory capital, potentially triggering downgrades. Downgraded insurers may need to de-risk, sell into falling markets, or slow new business — amplifying stress.
- Product repricing: To rebuild capital, insurers could cut crediting rates on annuities, raise premiums, or pull back on guarantees, affecting millions of retail policyholders.
- Feedback into credit markets: Forced sales or mark-downs would widen spreads and reduce credit availability to mid-market companies that depend on non-bank lenders.[5]
- Regulatory spillovers: The IMF has flagged private credit in insurers as a growing macro-prudential concern due to opacity, leverage, and interconnections with PE sponsors.[9][10][6]
How serious is the systemic risk right now?
Current Systemic Risk Assessment
Low / Contained
Elevated / Watch
Systemic / 2008-style
Rating agencies do not yet see an immediate 2008-style systemic threat. But the combination of rapid
growth, increasing complexity, ties to private equity owners, and the fact that most of this risk sits
in institutions the public views as safe makes Aronov's warning well-founded.
If valuations are significantly overstated and a liquidity event hits, the damage would be broad,
politically visible, and felt directly through ordinary insurance and retirement products — not just in
hedge fund returns.
Aronov's Core Warning
⁂